ANXA1 and breast cancer: ANXA1 expression was higher in the tumors from BRCA1/2 mutated patients compared to BCAC patients overall: 48.6 % versus 12.4 %, respectively; P <0.0001, and within specific breast cancer subtypes (Fig. 1).